Codeine phosphate

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Codeine phosphate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Paracetamol, Codeine Phosphate and Caffeine Capsules

Co-dydramol Tablets

Co-codamol Capsules

Co-codamol Tablets

Co-codamol Effervescent Tablets

Paracetamol, Codeine Phosphate and Caffeine Tablets

Morphine Tablets

Morphine Prolonged-release Tablets

Dihydrocodeine Prolonged-release Tablets

Morphine Prolonged-release Capsules

Morphine Granules for Oral Suspension

Dihydrocodeine Oral Solution

Co-codaprin Tablets

Dihydrocodeine Injection

Morphine Oral Solution

Dihydrocodeine Tablets

Morphine Suppositories

Morphine Capsules

Morphine Sulfate Injection

Codeine Phosphate Oral Solution

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Sales restrictions may apply.

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.